These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4980161)

  • 1. Detection of phenylketonuria carriers.
    Kelly S; Rose F
    Public Health Rep (1896); 1969 Feb; 84(2):144-8. PubMed ID: 4980161
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.
    De Groot CJ; Hommes FA
    Enzyme; 1982; 28(4):404-7. PubMed ID: 7151779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of heterozygotes of typical phenylketonuria].
    Farriaux JP; Delabre M
    Arch Fr Pediatr; 1972 Apr; 29(4):365-72. PubMed ID: 5053206
    [No Abstract]   [Full Text] [Related]  

  • 4. Discrimination of heterozygotes for phenylketonuria, persistent hyperphenylalaninemia and controls by phenylalanine loading.
    Blitzer MG; Bailey-Wilson JE; Shapira E
    Clin Chim Acta; 1986 Dec; 161(3):347-52. PubMed ID: 3802540
    [No Abstract]   [Full Text] [Related]  

  • 5. A simple method for detection of heterozygous carriers of the gene for classic phenylketonuria.
    Hilton MA; Sharpe JN; Hicks LG; Andrews BF
    J Pediatr; 1986 Oct; 109(4):601-4. PubMed ID: 3761073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Method of detection of heterozygotic carrier state in phenylketonuria].
    Baikov AD; Sitnichenko EI
    Lab Delo; 1973; 5():293-5. PubMed ID: 4129158
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    J Inherit Metab Dis; 1981; 4(2):73-4. PubMed ID: 6790854
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for PKU heterozygosity in bipolar affectively ill patients.
    Targum SD; Gershon ES; Shen RS; Abell CW
    Biol Psychiatry; 1979 Aug; 14(4):651-5. PubMed ID: 486619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Hum Genet; 1980; 54(2):213-6. PubMed ID: 7390492
    [No Abstract]   [Full Text] [Related]  

  • 10. The Guthrie screening test for phenylketonuria: a report on two years participation in the national programme.
    Becroft DM; Horn CR
    N Z Med J; 1969 Apr; 69(443):212-5. PubMed ID: 5254295
    [No Abstract]   [Full Text] [Related]  

  • 11. About changes of the phenylalanine-tyrosine metabolism in psoriasis vulgaris.
    Knapp A
    Acta Univ Carol Med (Praha); 1986; 32(3-4):203-6. PubMed ID: 3434474
    [No Abstract]   [Full Text] [Related]  

  • 12. The advantage of phenylalanine to tyrosine ratio for the early detection of phenylketonuria.
    Levy PA; Miller JB; Shapira E
    Clin Chim Acta; 1998 Feb; 270(2):177-81. PubMed ID: 9544454
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of heterozygous carriers for phenylketonuria by a L-[2H5]phenylalanine stable isotope loading test.
    Lehmann WD; Theobald N; Heinrich HC; Clemens P; Grüttner R
    Clin Chim Acta; 1984 Mar; 138(1):59-71. PubMed ID: 6713688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.
    Westwood A; Raine DN
    J Med Genet; 1975 Dec; 12(4):327-33. PubMed ID: 1219115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1654-60. PubMed ID: 890909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylketonuria. Mass screening of newborns in Ireland.
    Cahalane SF
    Arch Dis Child; 1968 Apr; 43(228):141-4. PubMed ID: 5645686
    [No Abstract]   [Full Text] [Related]  

  • 17. An enzymatic assay of plasma phenylalanine and tyrosine for the detection and management of phenylketonuria.
    Shen RS; Richardson CJ; Rouse BM; Abell CW
    Biochem Med; 1981 Oct; 26(2):211-21. PubMed ID: 7317039
    [No Abstract]   [Full Text] [Related]  

  • 18. Two siblings of hyperphenylalaninemia: suggestion to a genetic variant of phenylketonuria.
    Tada K; Yoshida T; Mochizuki K; Konno T; Nakagawa H
    Tohoku J Exp Med; 1970 Mar; 100(3):249-53. PubMed ID: 5442719
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mass screening of phenylketonuria. Report on a screening center (October 1967-December 1968)].
    Barbesier J; Boisse J; Charpentier C; Lemonnier A; Mozziconacci P
    Presse Med (1893); 1969 Sep; 77(37):1279-82. PubMed ID: 4897489
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylketonuria: a family study.
    Crosby PF; Navarro A; Matos ML
    Bol Asoc Med P R; 1969 Apr; 61(4):133-7. PubMed ID: 5255738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.